Healthcare provider profile · identity verified

Rishi Pathak, M.D.

Family Practice · KEIZER, OR · NPI 1982850152

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	742	232
Levothyroxine Sodium	Levothyroxine Sodium	448	138
Gabapentin	Gabapentin	390	141
Amlodipine Besylate	Amlodipine Besylate	368	115
Omeprazole	Omeprazole	358	124
Lisinopril	Lisinopril	296	108
Losartan Potassium	Losartan Potassium	288	99
Potassium Chloride	Potassium Chloride	261	77
Furosemide	Furosemide	243	68
Metformin Hcl	Metformin Hcl	210	68
Metoprolol Succinate	Metoprolol Succinate	209	68
Pantoprazole Sodium	Pantoprazole Sodium	198	55
Sertraline Hcl	Sertraline Hcl	190	51
Hydrochlorothiazide	Hydrochlorothiazide	189	66
Trazodone Hcl	Trazodone Hcl	182	64
Tamsulosin Hcl	Tamsulosin Hcl	168	60
Albuterol Sulfate Hfa	Albuterol Sulfate	152	65
Alendronate Sodium	Alendronate Sodium	150	46
Tizanidine Hcl	Tizanidine Hcl	149	61
Simvastatin	Simvastatin	145	51
Allopurinol	Allopurinol	126	44
Fluoxetine Hcl	Fluoxetine Hcl	119	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	119	52
Duloxetine Hcl	Duloxetine Hcl	114	36
Eliquis	Apixaban	107	28
Escitalopram Oxalate	Escitalopram Oxalate	106	31
Topiramate	Topiramate	105	30
Bupropion Xl	Bupropion Hcl	101	33
Rosuvastatin Calcium	Rosuvastatin Calcium	90	43
Donepezil Hcl	Donepezil Hcl	85	26
Carvedilol	Carvedilol	83	20
Pravastatin Sodium	Pravastatin Sodium	83	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	21
Zolpidem Tartrate	Zolpidem Tartrate	82	19
Fluticasone Propionate	Fluticasone Propionate	80	30
Buspirone Hcl	Buspirone Hcl	77	27
Ezetimibe	Ezetimibe	73	27
Lovastatin	Lovastatin	69	20
Metoprolol Tartrate	Metoprolol Tartrate	69	26
Warfarin Sodium	Warfarin Sodium	66	25
Meloxicam	Meloxicam	65	23
Cephalexin	Cephalexin	64	46
Trulicity	Dulaglutide	64	12
Metformin Hcl Er	Metformin Hcl	63	28
Lactulose	Lactulose	60	21
Montelukast Sodium	Montelukast Sodium	59	26
Alprazolam	Alprazolam	58	33
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	24
Atenolol	Atenolol	53	18
Mirtazapine	Mirtazapine	51	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	51	14
Amitriptyline Hcl	Amitriptyline Hcl	50	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	20
Ropinirole Hcl	Ropinirole Hcl	49	16
Pioglitazone Hcl	Pioglitazone Hcl	48	suppressed
Prednisone	Prednisone	48	36
Spironolactone	Spironolactone	47	17
Ozempic	Semaglutide	46	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	44	33
Lorazepam	Lorazepam	44	13
Citalopram Hbr	Citalopram Hydrobromide	42	11
Glipizide Er	Glipizide	42	12
Pregabalin	Pregabalin	41	14
Clonazepam	Clonazepam	40	12
Aripiprazole	Aripiprazole	39	suppressed
Famotidine	Famotidine	39	13
Ibuprofen	Ibuprofen	39	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	16
Prazosin Hcl	Prazosin Hcl	38	suppressed
Risperidone	Risperidone	38	suppressed
Ipratropium Bromide	Ipratropium Bromide	37	13
Clonidine Hcl	Clonidine Hcl	36	11
Azithromycin	Azithromycin	35	24
Baclofen	Baclofen	35	11
Oxycodone Hcl	Oxycodone Hcl	35	12
Propranolol Hcl	Propranolol Hcl	35	12
Nystatin	Nystatin	34	21
Ondansetron Odt	Ondansetron	33	suppressed
Chlorthalidone	Chlorthalidone	32	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Finasteride	Finasteride	31	suppressed
Glimepiride	Glimepiride	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	11
Estradiol	Estradiol	30	11
Meclizine Hcl	Meclizine Hcl	30	17
Tramadol Hcl	Tramadol Hcl	30	21
Hydroxyzine Pamoate	Hydroxyzine Pamoate	28	16
Midodrine Hcl	Midodrine Hcl	28	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	27	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Glipizide	Glipizide	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Olanzapine	Olanzapine	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	13
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	19
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Tresiba Flextouch U-200	Insulin Degludec	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	16
Doxycycline Hyclate	Doxycycline Hyclate	18	15
Promethazine Hcl	Promethazine Hcl	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Folic Acid	Folic Acid	17	suppressed
Primidone	Primidone	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Breyna	Budesonide/Formoterol Fumarate	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Valsartan	Valsartan	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nitroglycerin	Nitroglycerin	14	12
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Irbesartan	Irbesartan	13	suppressed
Methylphenidate Er	Methylphenidate Hcl	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Levocarnitine	Levocarnitine	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	11	11
Premarin	Estrogens, Conjugated	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error